MedPath

Neuromuscular Electrical Stimulation in Foot and Ankle Surgery

Not Applicable
Not yet recruiting
Conditions
Ankle Fractures
Interventions
Procedure: VPOD Wireless Tens Unit
Procedure: Physical Therapy
Device: Biodex
Registration Number
NCT06370325
Lead Sponsor
NYU Langone Health
Brief Summary

This is a pilot randomized controlled trial, wherein the intervention group will undergo NMES five days a week beginning three weeks postoperative and lasting for ten weeks. Both the control and intervention groups will start standard physical therapy six weeks postoperative. Primary outcome measure will be the isometric strength of the gastrocnemius muscle. The secondary outcomes will comprise subjective clinical evaluations (using the Lower Extremity Functional Scale \[LEFS\]), functional assessments such as the sit-to-stand test, 2-minute walk test, stair climb test and objective clinical evaluation using contralateral comparison of calf circumference.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Capable and willing to provide informed consent
  • Undergoing a procedure that involves repairing an ankle fracture.
Exclusion Criteria

Patients with medical histories that include:

  • Rheumatoid arthritis
  • Connective tissue disorders
  • Chronic corticosteroid use
  • Implanted electrical devices
  • Neurological disorders
  • Non-ambulatory status
  • Recent surgery (within the last 3 months) that is not related to the study
  • Scheduled to undergo surgery in the near future
  • Epilepsy
  • Diagnosed with cancer
  • Have suffered acute trauma or recently have had a surgical procedure (not related to the study)
  • Have cardiac problems or cardiac disease
  • Have an abdominal hernia
  • Have venous thrombosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupVPOD Wireless Tens UnitParticipants randomized to the intervention group will undergo neuromuscular electrical stimulation (NMES) five days a week beginning three weeks postoperative and lasting for ten weeks. The intervention group will begin standard physical therapy at six weeks postoperative.
Intervention GroupPhysical TherapyParticipants randomized to the intervention group will undergo neuromuscular electrical stimulation (NMES) five days a week beginning three weeks postoperative and lasting for ten weeks. The intervention group will begin standard physical therapy at six weeks postoperative.
Intervention GroupBiodexParticipants randomized to the intervention group will undergo neuromuscular electrical stimulation (NMES) five days a week beginning three weeks postoperative and lasting for ten weeks. The intervention group will begin standard physical therapy at six weeks postoperative.
Control GroupBiodexParticipants randomized to the control group will begin standard physical therapy at six weeks postoperative.
Control GroupPhysical TherapyParticipants randomized to the control group will begin standard physical therapy at six weeks postoperative.
Primary Outcome Measures
NameTimeMethod
Isometric Strength of Gastrocnemius MuscleWeek 12

Measured using Biodex dynamometer.

Bilateral Calf CircumferenceWeek 12
Secondary Outcome Measures
NameTimeMethod
Sit-to-Stand TestWeek 12

The sit-to-stand test involves recording the number of stands a person can complete in 30 seconds.

Stair Climb TestWeek 12

The stair climb test measures the amount of time a person ascends and descends a flight of stairs, while walking as quickly as they feel safe and comfortable to move.

2 Minute Walk TestWeek 12

In this activity, the participant is encouraged to walk as fast as they can, safely, without assistance for two minutes and the distance is measured

Lower Extremity Functional Scale (LEFS) Questionnaire ScoreWeek 12

LEFS is a 20-item questionnaire assessing functional impairment in patients with disorders affecting one or both lower extremities. Each item is rated on a scale ranging from 0 to 4: 0 indicates inability to perform the activity or extreme difficulty, 1 indicates considerable difficulty, 2 indicates moderate difficulty, 3 indicates slight difficulty, and 4 indicates no difficulty. The score is the sum of responses and ranges from a minimum of 0 to a maximum of 80, with lower scores indicating greater disability.

Trial Locations

Locations (1)

NYU Langone Health

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath